- Home
- GCBC vs ETON Comparison
GCBC vs ETON Comparison
Compare GCBC & ETON Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GCBC
- ETON
- Stock Information
- Founded
- GCBC 1889
- ETON 2017
- Country
- GCBC United States
- ETON United States
- Employees
- GCBC N/A
- ETON N/A
- Industry
- GCBC Banks
- ETON Biotechnology: Pharmaceutical Preparations
- Sector
- GCBC Finance
- ETON Health Care
- Exchange
- GCBC Nasdaq
- ETON Nasdaq
- Market Cap
- GCBC 364.4M
- ETON 428.5M
- IPO Year
- GCBC 1998
- ETON 2018
- Fundamental
- Price
- GCBC $22.70
- ETON $17.33
- Analyst Decision
- GCBC
- ETON Strong Buy
- Analyst Count
- GCBC 0
- ETON 3
- Target Price
- GCBC N/A
- ETON $27.67
- AVG Volume (30 Days)
- GCBC 25.6K
- ETON 221.4K
- Earning Date
- GCBC 04-22-2025
- ETON 05-13-2025
- Dividend Yield
- GCBC 1.60%
- ETON N/A
- EPS Growth
- GCBC 16.16
- ETON N/A
- EPS
- GCBC 1.67
- ETON N/A
- Revenue
- GCBC $69,414,000.00
- ETON $39,011,000.00
- Revenue This Year
- GCBC N/A
- ETON $92.33
- Revenue Next Year
- GCBC N/A
- ETON $52.62
- P/E Ratio
- GCBC $13.15
- ETON N/A
- Revenue Growth
- GCBC 7.46
- ETON 23.29
- 52 Week Low
- GCBC $20.00
- ETON $3.18
- 52 Week High
- GCBC $37.25
- ETON $18.41
- Technical
- Relative Strength Index (RSI)
- GCBC 53.24
- ETON 68.29
- Support Level
- GCBC $21.91
- ETON $16.43
- Resistance Level
- GCBC $22.91
- ETON $17.49
- Average True Range (ATR)
- GCBC 0.90
- ETON 0.88
- MACD
- GCBC 0.21
- ETON 0.19
- Stochastic Oscillator
- GCBC 85.95
- ETON 92.78
About GCBC Greene County Bancorp Inc.
Greene County Bancorp Inc is a holding firm. Its primary business involves overseeing and directing the business of The Bank of Greene County and monitoring its cash position. Through its directly and indirectly owned subsidiaries, the company engages in attracting retail deposits, along with funds generated from operations and borrowings, predominantly in one to four-family residential mortgage loans, commercial real estate mortgage loans, consumer loans, home equity loans, and commercial business loans. It also serves local municipalities' banking needs and operates a real estate investment trust.
About ETON Eton Pharmaceuticals Inc.
Eton Pharmaceuticals Inc is a United States based specialty pharmaceutical company. The company is engaged in developing and commercializing pharmaceutical products to fulfill an unmet patient need. It has four commercial rare disease products, Alkindi Sprinkle for the treatment of adrenocortical insufficiency; Carglumic Acid for the treatment of hyperammonemia, Betaine Anhydrous for the treatment of homocystinuria; and Nitisinone for the treatment of hereditary tyrosinemia type 1 (HT-1). The Company has three additional product candidates in late-stage development: ET-400, ET-600, and ZENEO hydrocortisone autoinjector.